Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Histoplasmosis
100%
Histoplasma Capsulatum
46%
Paracoccidioidomycosis
41%
Paracoccidioides Brasiliensis
38%
Colombia
34%
Enzyme-linked Immunosorbent Assay (ELISA)
33%
Respiratory Syncytial Virus
32%
Melanin
31%
Conidia
27%
Fungi
26%
Latently Infected
24%
Monoclonal Antibody
23%
People Living with HIV (PLHIV)
22%
H. Capsulatum
20%
Latin America (LATAM)
20%
Yeast Cells
19%
P. Brasiliensis
19%
Macrophages
18%
Candida Species
17%
Infected Cells
17%
Virus
16%
Progressive Disseminated Histoplasmosis
16%
Macrophage-like
15%
Disseminated Histoplasmosis
14%
Endemic Mycoses
14%
Candida Albicans (C. albicans)
13%
Lung
13%
Lateral Flow Assay
12%
Histoplasma Antigen
11%
Mycoses
11%
Rubella
11%
Melanin-like
11%
Candida
10%
Antigen Test
10%
Colombians
10%
Co-infection
10%
Fungal PCR
10%
Quantitative PCR
10%
Antigenuria
10%
Viral Antigens
10%
Antibody Detection
9%
Fungal Pathogens
9%
Dimorphic Fungi
9%
Rapid Diagnosis
9%
Itraconazole
9%
Concordance Analysis
9%
Formalin-fixed Paraffin-embedded Tissue
9%
Extracellular Matrix Protein 1 (ECM1)
9%
Rubella Virus
9%
Molecular Targets
9%
Immunology and Microbiology
Ajellomyces capsulatus
47%
Paracoccidioides brasiliensis
44%
Infectious Agent
37%
Macrophage
35%
Human immunodeficiency virus
33%
Conidium
33%
Human respiratory syncytial virus
32%
Enzyme-Linked Immunosorbent Assay
31%
Monoclonal Antibody
31%
Candida
26%
Virus
24%
Yeast Cell
23%
Histoplasma
22%
Candida albicans
21%
Lateral Flow Assay
16%
Immune Response
15%
Rubella
13%
Cell Line
13%
Cell Wall
11%
Coinfection
11%
Cell Surface
11%
Virus Antigen
10%
Real Time Polymerase Chain Reaction
10%
ELISA
10%
Immunodiffusion
10%
Titer
10%
Immunocompromised Patient
10%
Immunofluorescence
9%
Programmed Cell Death
9%
Cerebrospinal Fluid
9%
Rubella Virus
9%
Matrix Protein
9%
Extracellular Matrix
9%
Minimum Inhibitory Concentration
9%
Microorganism
9%
Matrix-Assisted Laser Desorption-Ionization
9%
Cross-Reactivity
9%
Antibody Response
9%
Virus Infectivity
8%
Mycelium
8%
Human Alphaherpesvirus 1
8%
Mould
8%
Bagg Albino Mouse
8%
Paracoccidioides
8%
Complement Fixation
7%
Acquired Immune Deficiency Syndrome
7%
Cryptococcus neoformans
7%
Hemagglutination
7%
Antifungal Susceptibility
7%
Time-of-Flight Mass Spectrometry
7%